Our services
SCI represents Agendia in the MENA region. Agendia is a global US-based leader in innovative genomic technology and diagnostic tests, offering Mammaprint for assessment of Breast Cancer Recurrence. In addition, SCI distributes Natera’s prenatal and oncology diagnostic tests: Panorama and Signatera respectively.
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology and women’s health. SCI also partnered with Omicure in France and Pathgroup in the US, to provide clinicians with genomic diagnostic oncology tests which help support physicians in their complex treatment decisions in cancer management. SCI has expanded its scope of activity to include Cenata prenatal diagnostic tests.
Moreover, through its collaboration with Neoscreen and Blueprint Genetics, SCI offers a comprehensive and advanced portfolio of genetic panels for the diagnosis of disease in different specialties such as cardiology, pediatrics, metabolic disorders, hereditary cancers and more. SCI portfolio also includes 4K score test, the advanced risk assessment test for prostate cancer exclusively performed at GenPath in the United States, and VisioCyt, a bladder cancer diagnostic powered by artificial intelligence and performed at VitaDX in France.
Our services & partners
Our vision
Our vision is to become the leading provider of cutting-edge oncology and genetic testing solutions that enable earlier detection, higher accuracy, and personalized treatment plans.
We strive to empower clinicians with the tools they need to provide the best possible care for their patients, while making these tests accessible and affordable for everyone who needs them.
As a company, we are committed to advancing the field of genetics and oncology through innovation and collaboration with leading experts in the industry. At the core of our vision is a commitment to putting patients first.
By providing accurate and timely diagnoses, we can give patients and their families the information they need to make informed decisions and take control of their health.
Our goal is to transform the way healthcare is delivered, making it more personalized, effective, and compassionate.